Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ampicillin/Sulbactam and Amoxicillin/Clavulanic Acid PK in Hemodialysis
NCT02007603Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Aug 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ampicillin, sulbactam, amoxicillin, clavulanic acid in bacterial infection, sponsored by Medical University of Vienna. Started Aug 2013; status: completed.
02
Drugs
ampicillinsulbactamamoxicillinclavulanic acid
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02007603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02007603.